Bayer Wins China Approval for Stroke-Prevention Drug in New Class
Bayer said China authorized asundexian to prevent recurrent stroke, making it the first approved drug in a new class of blood thinners.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bayer Wins First Global Approval for Stroke Prevention Drug in China
Bayer said China authorized the launch of its drug to prevent recurrent stroke, marking the first global approval for a new class of medicines.